(1) "Cancer drug" means a prescription drug that is used to treat cancer or the side effects of cancer.

(2) "Department" means the department of public health and environment.

(3) "Dispense" shall have the same meaning as set forth in section 12-42.5-102 (11), C.R.S.

(4) "Eligible patient" means an uninsured or underinsured cancer patient who meets the eligibility criteria established in rule by the state board.

(5) "Health care facility" means a hospital, hospice, or hospital unit that is required to be licensed pursuant to section 25-3-101.

(6) "Medical clinic" means a community health clinic required to be licensed or certified by the department pursuant to section 25-1.5-103.

(7) "Medical device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component, part, or accessary that is:

(a) Recognized in the official national formulary, or the United States pharmacopoeia, or any supplement;

(b) Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in humans or animals; or

(c) Intended to affect the structure or any function of the human body or animals, that does not achieve any of its primary intended purposes through chemical action within or on the human body or animals, and that is not dependent upon being metabolized for the achievement of any of its primary intended purposes.

(8) "Pharmacist" means an individual licensed by this state pursuant to article 42.5 of title 12, C.R.S., to engage in the practice of pharmacy.

(9) "Program" means the Colorado cancer drug repository program created in section 25-35-103.

(10) "State board" means the state board of health.